|
Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
RECRUITINGN/ASponsored by Xijing Hospital
Actively Recruiting
PhaseN/A
SponsorXijing Hospital
Started2023-09-01
Est. completion2025-12-31
Eligibility
Age20 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06082531
Summary
To evaluate the safety and effectiveness of PRP injection therapy in the repair of osteoarthritis and periarticular soft tissue injury through a single-center, exploratory clinical study, and to provide a more reliable basis for the treatment of joint injury.
Eligibility
Age: 20 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria: * The age range of the participants was 20 to 60 years old. Through a comprehensive clinical and imaging examination, it was conclusively determined that the individuals had knee osteoarthritis or experienced injuries to the cart, and meniscus surrounding the knee joint. * The preoperative routine tests and examinations revealed no contraindications. * Revised sentence: "Informed consent of the patient Exclusion Criteria: * The platelet count or function exhibits significant abnormalities、Systemic infection transmitted through the bloodstream. * Prolonged usage of anti-inflammatory drugs and systemic corticoid administration. * In injection site or damage to the skin. * Patients with tumors or undergoing radiotherapy and chemotherapy. * Pregnant or breastfeeding women. * Individuals with mental illnesses who are unable to cooperate with follow-up procedures. * Contraindications for MRI、Patients or their families do consent to participate in the study. * Other circumstances that render participation in the study unsuitable.
Conditions5
ArthritisCartilage InjuryMeniscus DisorderOsteoarthritis Knees BothPlatelets-rich Plasma
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorXijing Hospital
Started2023-09-01
Est. completion2025-12-31
Eligibility
Age20 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06082531